Next report date
Report period
Q1 2024
EPS estimate
−0.17USD
Revenue estimate
—
−1.1572USD
−39.76 MUSD
30.89 M
About Better Therapeutics, Inc.
Sector
Industry
CEO
Craig R. Jalbert
Website
Headquarters
San Francisco
Employees (FY)
54
Founded
2015
FIGI
BBG00YZ55XT6
Better Therapeutics, Inc. operates as a digital therapeutics company, which engages in developing a novel form of cognitive behavioral therapy to address the root causes of cardio metabolic diseases. It offers software-based solutions for type 2 diabetes, heart disease and other conditions. The company was founded by Kevin J. Appelbaum and David P. Perry in April 2015 and is headquartered in San Francisco, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of BTTX is 0.0090 USD — it has increased by 15.68% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Better Therapeutics, Inc. stocks are traded under the ticker BTTX.
Better Therapeutics, Inc. is going to release the next earnings report on May 10, 2024. Keep track of upcoming events with our Earnings Calendar.
BTTX stock is 90.25% volatile and has beta coefficient of 2.27. Check out the list of the most volatile stocks — is Better Therapeutics, Inc. there?
BTTX earnings for the last quarter are −0.15 USD per share, whereas the estimation was −0.20 USD resulting in a 23.08% surprise. The estimated earnings for the next quarter are −0.12 USD per share. See more details about Better Therapeutics, Inc. earnings.
Yes, you can track Better Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
BTTX stock hasn't changed in a week, the month change is a 48.57% fall, over the last year Better Therapeutics, Inc. has showed a 99.31% decrease.
BTTX net income for the last quarter is −5.86 M USD, while the quarter before that showed −7.59 M USD of net income which accounts for 22.76% change. Track more Better Therapeutics, Inc. financial stats to get the full picture.
Today Better Therapeutics, Inc. has the market capitalization of 489.17 K, it has decreased by 34.55% over the last week.
No, BTTX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BTTX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Better Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 26, 2024, the company has 54.00 employees. See our rating of the largest employees — is Better Therapeutics, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Better Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Better Therapeutics, Inc. stock shows the sell signal. See more of Better Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.